"synopsis" may belong to another edition of this title.
"About this title" may belong to another edition of this title.
Shipping:
US$ 3.99
Within U.S.A.
Book Description Condition: New. Seller Inventory # ABLIING23Mar3113020262696
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783659108365_lsuk
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9783659108365
Book Description PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659108365
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -A major obstacle in Tuberculosis (TB) control is the long duration of treatment. Therefore, treatment shortening is one of the highest priorities for TB control programs worldwide. Fluoroquinolones (FQ) have been found to be highly active against Mycobacterium Tuberculosis and recommended as second line agents for TB treatment. Recent evidences have shown that the newer generation FQ add to the effects of existing anti-TB drugs and perhaps allow TB treatment to be shortened. However, no review has been published on the role of FQ in shortening TB treatment duration. This book, therefore, is questioning whether FQ can shorten TB treatment duration. The study has used systematic review and meta-analysis method to synthesize, critically appraise and update all relevant clinical studies on the use of FQ for drug susceptible TB in shortening treatment duration. It included 10 studies from comprehensive search of electronic databases. The review will help highlight the challenges around the use of FQ in tuberculosis which will be of great importance in justifying shortening TB treatment duration. 96 pp. Englisch. Seller Inventory # 9783659108365
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A major obstacle in Tuberculosis (TB) control is the long duration of treatment. Therefore, treatment shortening is one of the highest priorities for TB control programs worldwide. Fluoroquinolones (FQ) have been found to be highly active against Mycobacterium Tuberculosis and recommended as second line agents for TB treatment. Recent evidences have shown that the newer generation FQ add to the effects of existing anti-TB drugs and perhaps allow TB treatment to be shortened. However, no review has been published on the role of FQ in shortening TB treatment duration. This book, therefore, is questioning whether FQ can shorten TB treatment duration. The study has used systematic review and meta-analysis method to synthesize, critically appraise and update all relevant clinical studies on the use of FQ for drug susceptible TB in shortening treatment duration. It included 10 studies from comprehensive search of electronic databases. The review will help highlight the challenges around the use of FQ in tuberculosis which will be of great importance in justifying shortening TB treatment duration. Seller Inventory # 9783659108365
Book Description PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783659108365
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Wah WinWin Wah, a medical dr from Myanmar, obtained Master of Public Health from University of Sheffield & Advanced Public Health Methods Master from University of Copenhagen under Europubhealth programme (2009-2011). She has been wo. Seller Inventory # 5131883